DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Cymabay Therapeutics Inc. (CBAY)
« Back to company indexCBAY Chatter Timeline
Stock Ticker for CBAY
Most Active Tweeters for CBAY
No tweets foundRecent Tweets for CBAY
 |
@TheMarketsDaily Zacks: Analysts Expect CymaBay Therapeutics Inc $CBAY Will Post Earnings of -$0.30 Per Share https://t.co/JT5V83ycWv August 20th 2018, 5:08pm |
 |
@MareaInformativ Analysts Issue Forecasts for CymaBay Therapeutics Inc’s Q3 2019 Earnings $CBAY https://t.co/aASkb4yPTT August 20th 2018, 6:08am |
 |
@bibeypost_stock Are Analysts Bullish about CymaBay Therapeutics, Inc. $CBAY after last week? - https://t.co/4aCWLiq6cp August 19th 2018, 4:08pm |
 |
@reurope_stock Are Analysts Bullish CymaBay Therapeutics, Inc. $CBAY After Last Week? https://t.co/UYzVwp2PNt August 19th 2018, 4:08pm |
 |
@mmahotstuff1 This is what analysts have to say about CymaBay Therapeutics, Inc. $CBAY after last week. - https://t.co/Updn62VG0v August 19th 2018, 4:08pm |
 |
@whatsonthorold2 Here's how analysts see CymaBay Therapeutics, Inc. $CBAY after this past week. - https://t.co/kTeQIshXLQ August 19th 2018, 4:08pm |
 |
@west_moreland How Many CymaBay Therapeutics, Inc. $CBAY's Analysts Are Bearish? https://t.co/TqGPoGwo5K August 19th 2018, 4:08pm |
 |
@Fanob_stock CymaBay Therapeutics, Inc. $CBAY has analysts on the Bullish side this week. https://t.co/WJ1jWhhA5C August 19th 2018, 4:08pm |
 |
@EnterpriseLeade Oppenheimer Reiterates “$20.00” Price Target for CymaBay Therapeutics $CBAY https://t.co/fjhrlcxwQa August 19th 2018, 11:08am |
 |
@registrarjourn CymaBay Therapeutics $CBAY PT Raised to $30.00 at Piper Jaffray Companies https://t.co/yHfZAlHf6O August 18th 2018, 5:08pm |
|
@EnterpriseLeade CymaBay Therapeutics $CBAY PT Raised to $30.00 at Piper Jaffray Companies https://t.co/XXZDPdBsMk August 18th 2018, 5:08pm |
|
@registrarjourn -$0.25 EPS Expected for CymaBay Therapeutics Inc $CBAY This Quarter https://t.co/ZVfNhIqKQT August 18th 2018, 5:08pm |
|
@EnterpriseLeade -$0.25 EPS Expected for CymaBay Therapeutics Inc $CBAY This Quarter https://t.co/Cm0UifGj2g August 18th 2018, 5:08pm |
|
@MareaInformativ Brokerages Anticipate CymaBay Therapeutics Inc $CBAY to Post -$0.30 Earnings Per Share https://t.co/ekhDH60l9c August 18th 2018, 1:08pm |
 |
@beyond_ninety Putnam Investments Decreased Cymabay Therapeutics $CBAY Holding; Las Vegas Sands $LVS Sentiment Is 1.14 https://t.co/4N3ZhLV9Ar August 18th 2018, 12:08pm |
 |
@dailypoliticaln CymaBay Therapeutics Inc $CBAY Expected to Post Q3 2018 Earnings of -$0.31 Per Share https://t.co/vpA8HkU1rE August 18th 2018, 1:08am |
 |
@TickerReport CymaBay Therapeutics Inc $CBAY Expected to Post Q3 2018 Earnings of -$0.31 Per Share https://t.co/TAUidz9sK1 August 18th 2018, 1:08am |
 |
@DemunF Binance registration is currently open Register link and BONUS ? https://t.co/UBgaTRVvIV ? 08/17 09:25 $PNK $CBAY… https://t.co/dq7Eqo4rx7 August 17th 2018, 9:08pm |
 |
@usindexlive Cymabay $CBAY Shareholder Abingworth Llp Lowered Its Holding by $10.48 Million as Share Value Declined; Parker Hann… https://t.co/e8oM0NrjCJ August 17th 2018, 10:08am |
|
@MareaInformativ CymaBay Therapeutics $CBAY Given a $20.00 Price Target at Oppenheimer https://t.co/g78UkCH7BX August 17th 2018, 7:08am |
 |
@bbnsnews Q3 2018 EPS Estimates for CymaBay Therapeutics Inc $CBAY Cut by SunTrust Banks https://t.co/lz58U1naem August 17th 2018, 7:08am |
 |
@WatchlistN FY2018 EPS Estimates for CymaBay Therapeutics Inc $CBAY Decreased by Cantor Fitzgerald https://t.co/EHpyG88JEo August 17th 2018, 3:08am |
|
@usindexlive As Cymabay $CBAY Share Price Declined, Shareholder Abingworth Llp Has Decreased Its Stake; Sorin Capital Management… https://t.co/wiMsZbzZOv August 16th 2018, 11:08am |
 |
@OlympiaReport Research Analysts Issue Forecasts for CymaBay Therapeutics Inc’s Q3 2018 Earnings $CBAY https://t.co/l5Qe59ix0y August 16th 2018, 9:08am |
 |
@AmericanBanking Research Analysts Issue Forecasts for CymaBay Therapeutics Inc’s Q3 2018 Earnings $CBAY https://t.co/hEIPhyBEx5 #stocks August 16th 2018, 9:08am |
 |
@WeekHerald Research Analysts Issue Forecasts for CymaBay Therapeutics Inc’s Q3 2018 Earnings $CBAY https://t.co/oByo44DdmJ August 16th 2018, 9:08am |
 |
@1MinuteStock We calculated 63-day Expected Return of $CBAY for you: 2.33% https://t.co/dkVwertBjC August 16th 2018, 8:08am |
 |
@BroigTyme @Lblegend33 @odibro $cbay CEO bought a few hundred dollars worth a few weeks ago, yet he gets no credit August 16th 2018, 7:08am |
|
@TickerReport FY2018 EPS Estimates for CymaBay Therapeutics Inc $CBAY Reduced by Analyst https://t.co/GEWEZCcqVq August 16th 2018, 2:08am |
|
@dailypoliticaln FY2018 EPS Estimates for CymaBay Therapeutics Inc $CBAY Reduced by Analyst https://t.co/EcA0kUcVoX August 16th 2018, 2:08am |
 |
@TranscriptDaily CymaBay Therapeutics Inc $CBAY to Post Q3 2019 Earnings of -$0.36 Per Share, Leerink Swann Forecasts https://t.co/8DzXkZ9wRH August 15th 2018, 5:08pm |
|
@AmericanBanking Cantor Fitzgerald Brokers Reduce Earnings Estimates for CymaBay Therapeutics Inc $CBAY https://t.co/jpC3vTxq1S #stocks August 15th 2018, 8:08am |
 |
@ConsumerFeed Cantor Fitzgerald Brokers Reduce Earnings Estimates for CymaBay Therapeutics Inc $CBAY https://t.co/eBznQs6gbw August 15th 2018, 8:08am |
|
@OlympiaReport Brokerages Anticipate CymaBay Therapeutics Inc $CBAY Will Announce Earnings of -$0.29 Per Share https://t.co/RVvF0Tg4SZ August 15th 2018, 2:08am |
|
@AmericanBanking Brokerages Anticipate CymaBay Therapeutics Inc $CBAY Will Announce Earnings of -$0.29 Per Share https://t.co/Xc6hUBzWcI #stocks August 15th 2018, 2:08am |
|
@WeekHerald CymaBay Therapeutics Inc $CBAY Expected to Announce Earnings of -$0.29 Per Share https://t.co/PRzhxZvwoM August 15th 2018, 2:08am |
|
@TickerReport CymaBay Therapeutics Inc Expected to Post Q3 2019 Earnings of -$0.36 Per Share $CBAY https://t.co/3eiS3VQvtK August 14th 2018, 8:08am |
|
@WatchlistN CymaBay Therapeutics Inc Expected to Post Q3 2019 Earnings of -$0.36 Per Share $CBAY https://t.co/imFfXHKYvT August 14th 2018, 8:08am |
 |
@GNWLive CymaBay Therapeutics to Participate in Upcoming Investor Conferences in August and September $CBAY https://t.co/HpmFW51MmI August 14th 2018, 8:08am |
|
@OlympiaReport Piper Jaffray Companies Raises CymaBay Therapeutics $CBAY Price Target to $30.00 https://t.co/4nNlqGilGd August 14th 2018, 5:08am |
|
@registrarjourn CymaBay Therapeutics $CBAY Receives Daily Coverage Optimism Rating of 0.13 https://t.co/TponEv7953 August 13th 2018, 8:08pm |
|
@EnterpriseLeade CymaBay Therapeutics $CBAY Receives Daily Coverage Optimism Rating of 0.13 https://t.co/tC9iPb8HrG August 13th 2018, 8:08pm |
 |
@brendan_49 Back in 2011 $CBAY seladelpar failed to beat a statin in lipid and cholesterol reduction but was safe at v high dos… https://t.co/lsjVW1shIS August 13th 2018, 6:08pm |
|
@brendan_49 32/32 eligible patients in $CBAY phase 2 study in an autoimmune liver disease opted to continue on drug when given… https://t.co/Fo7QeJdb3I August 13th 2018, 6:08pm |
|
@TranscriptDaily Piper Jaffray Companies Raises CymaBay Therapeutics $CBAY Price Target to $30.00 https://t.co/H0X1vrGBur August 13th 2018, 11:08am |
|
@beyond_ninety Cymabay $CBAY Shareholder Abingworth Llp Has Cut Holding by $10.48 Million; Berkshire Hathaway Holding in Phillips… https://t.co/mDW30SS7eX August 13th 2018, 7:08am |
|
@AmericanBanking Equities Analysts Offer Predictions for CymaBay Therapeutics Inc’s Q3 2019 Earnings $CBAY https://t.co/iThdrnXxqn #stocks August 13th 2018, 7:08am |
|
@TheMarketsDaily Equities Analysts Offer Predictions for CymaBay Therapeutics Inc’s Q3 2019 Earnings $CBAY https://t.co/AMzMCGb8pR August 13th 2018, 6:08am |
|
@MareaInformativ Equities Analysts Offer Predictions for CymaBay Therapeutics Inc’s Q3 2019 Earnings $CBAY https://t.co/aASkb4yPTT August 13th 2018, 6:08am |
 |
@RatingsNetwork Leerink Swann Sets CymaBay Therapeutics Q3 2019 Earnings Estimates at ($0.36) EPS. https://t.co/6tx8DByLcx $CBAY #CBAY August 13th 2018, 6:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2018. All rights reserved.